These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22823481)

  • 1. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.
    Hottinger A; Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2012 Sep; 26(9):761-72. PubMed ID: 22823481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
    Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of topiramate in adult refractory status epilepticus: experience of a tertiary care center.
    Synowiec AS; Yandora KA; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2012 Feb; 98(2-3):232-7. PubMed ID: 22000869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of topiramate in refractory status epilepticus.
    Towne AR; Garnett LK; Waterhouse EJ; Morton LD; DeLorenzo RJ
    Neurology; 2003 Jan; 60(2):332-4. PubMed ID: 12552056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory generalized convulsive status epilepticus with enteral topiramate in resource limited settings.
    Asadi-Pooya AA; Jahromi MJ; Izadi S; Emami Y
    Seizure; 2015 Jan; 24():114-7. PubMed ID: 25458103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate loading for refractory status epilepticus in children.
    Perry MS; Holt PJ; Sladky JT
    Epilepsia; 2006 Jun; 47(6):1070-1. PubMed ID: 16822255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propofol treatment of refractory status epilepticus: a study of 31 episodes.
    Rossetti AO; Reichhart MD; Schaller MD; Despland PA; Bogousslavsky J
    Epilepsia; 2004 Jul; 45(7):757-63. PubMed ID: 15230698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of refractory status epilepticus: an update.
    Lowenstein DH
    Epilepsia; 2006; 47 Suppl 1():35-40. PubMed ID: 17044824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early polytherapy for benzodiazepine-refractory status epilepticus.
    Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
    Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral topiramate as an add-on treatment for refractory status epilepticus.
    Stojanova V; Rossetti AO
    Acta Neurol Scand; 2012 Feb; 125(2):e7-e11. PubMed ID: 21711264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
    Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
    Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
    Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.
    Rohracher A; Höfler J; Kalss G; Leitinger M; Kuchukhidze G; Deak I; Dobesberger J; Novak H; Pilz G; Zerbs A; Trinka E
    Epilepsy Behav; 2015 Aug; 49():354-8. PubMed ID: 25962657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine use in the treatment of refractory status epilepticus.
    Synowiec AS; Singh DS; Yenugadhati V; Valeriano JP; Schramke CJ; Kelly KM
    Epilepsy Res; 2013 Jul; 105(1-2):183-8. PubMed ID: 23369676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perampanel Treatment for Refractory Status Epilepticus in a Neurological Intensive Care Unit.
    Ho CJ; Lin CH; Lu YT; Shih FY; Hsu CW; Tsai WC; Tsai MH
    Neurocrit Care; 2019 Aug; 31(1):24-29. PubMed ID: 30891695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of refractory and superrefractory status epilepticus with topiramate: A cohort study of 106 patients and a review of the literature.
    Fechner A; Hubert K; Jahnke K; Knake S; Konczalla J; Menzler K; Ronellenfitsch MW; Rosenow F; Strzelczyk A
    Epilepsia; 2019 Dec; 60(12):2448-2458. PubMed ID: 31713232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
    Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
    Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
    Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
    Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric refractory partial status epilepticus responsive to topiramate.
    Blumkin L; Lerman-Sagie T; Houri T; Gilad E; Nissenkorn A; Ginsberg M; Watemberg N
    J Child Neurol; 2005 Mar; 20(3):239-41. PubMed ID: 15832617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.